Akebia Therapeutics (AKBA) Gross Profit (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Gross Profit of $41.3 million for Q1 2026, down 17.01% year-over-year from $49.7 million in Q1 2025, and down 8.5% quarter-over-quarter from $45.1 million in Q4 2025.
Akebia Therapeutics (AKBA) Gross Profit (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Gross Profit for 9 consecutive years, with $41.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit fell 17.01% year-over-year to $41.3 million; the TTM figure through Mar 2026 stood at $188.3 million (up 30.99% YoY), while the FY2025 annual figure was $196.7 million, up 47.87% from the prior year.
- Gross Profit slipped to $41.3 million in Q1 2026 per AKBA's latest filing, from $45.1 million in the prior quarter.
- Across five years, Gross Profit topped out at $107.8 million in Q2 2022 and bottomed at -$23.0 million in Q1 2022.
- Historically, Gross Profit has averaged $36.4 million across 5 years, with a median of $35.1 million in 2024.
- On a YoY basis, Gross Profit climbed as much as 1042.91% in 2022 and fell as far as 186.22% in 2022.
- Akebia Therapeutics' Gross Profit stood at $32.2 million in 2022, then surged by 44.63% to $46.5 million in 2023, then retreated by 24.49% to $35.1 million in 2024, then rose by 28.3% to $45.1 million in 2025, then retreated by 8.5% to $41.3 million in 2026.
- Business Quant data shows AKBA's Gross Profit at $41.3 million in Q1 2026, $45.1 million in Q4 2025, and $49.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.70 Mn |
| Jun 30, 2026 | 38.70 Mn |
| Mar 31, 2026 | 41.25 Mn |
| Mar 31, 2026 | 41.25 Mn |
| Dec 31, 2025 | 45.09 Mn |
| Dec 31, 2025 | 45.09 Mn |
| Sep 30, 2025 | 49.38 Mn |
| Sep 30, 2025 | 49.38 Mn |
| Jun 30, 2025 | 52.55 Mn |
| Jun 30, 2025 | 52.55 Mn |
| Mar 31, 2025 | 49.71 Mn |
| Mar 31, 2025 | 49.71 Mn |
| Dec 31, 2024 | 35.14 Mn |
| Dec 31, 2024 | 35.14 Mn |
| Sep 30, 2024 | 32.28 Mn |
| Sep 30, 2024 | 32.28 Mn |
| Jun 30, 2024 | 26.60 Mn |
| Jun 30, 2024 | 26.60 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Mar 31, 2024 | 21.00 Mn |